Emulate

Articles

Modeling Complex Human Immune Response in the Colon Intestine-Chip 

Recapitulating Inflammation: How to Use the Colon Intestine-Chip to Study Complex Mechanisms of IBD 

A classically trained pharmacologist, Dr. Ewart spent 20 years at AstraZeneca, where she successfully established and led the Microphysiological Systems Centre of Excellence within the R&D Biopharmaceuticals Unit. Throughout her tenure at AstraZeneca, Dr. Ewart held additional roles of increasing responsibility, including Director of Toxicology Projects (Respiratory, Inflammation and Autoimmune). She obtained her honors degree at the University of Aberdeen and her PhD at the William Harvey Research Institute in London. She is a frequent author on publications showcasing the applicability of organ-on-a-chip technology, a sought-after keynote speaker at conferences surrounding the advancement of alternative methods, and a fellow of the Royal Society of Biology and British Pharmacological Society.

Organ-on-a-Chip technology has been proven to predict DILI with a higher rate of confidence than traditional in vitro methods and animals. Start protecting human health today. 